
10/17/2017 – iShares NASDAQ Biotechnology ETF (IBB)
With renewed talks from the POTUS regarding drug pricing, let's review some charts for the biotech technology sector. Specifically, I am going to analyze the charts for the iShares NASDAQ Biotechnology ETF (IBB). Are the talks coming out of the White House going to slow down any potential rebounds for the...
You must be logged in to post a comment.